Boule Diagnostics AB (publ) reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 140.3 million compared to SEK 92.7 million a year ago. Net income was SEK 17.3 million compared to net loss of SEK 32.6 million a year ago.

Basic earnings per share from continuing operations was SEK 0.89 compared to basic loss per share from continuing operations of SEK 1.68 a year ago. Diluted earnings per share from continuing operations was SEK 0.87 compared to diluted loss per share from continuing operations of SEK 1.63 a year ago.